Overview

• President Claudia Sheinbaum said companies had until Sept. 30 to complete deliveries or face penalties starting Oct. 1.
• Sheinbaum guaranteed that government arrears to pharmaceutical suppliers will be paid but insisted firms must fulfill their contracts.
• Industry leaders welcomed the payment pledge, and Canifarma’s Guillermo Funes estimated the debt could be settled within two months.
• A case-by-case working group is reviewing non-delivery claims, and Funes noted only two companies on the government’s list belong to Canifarma.
• Executives cited logistics, import permits, customs checks and COFEPRIS reviews as ongoing obstacles, with overall deliveries around 60 percent by August and IMSS‑Bienestar previously the most delayed.